New combo could make inoperable liver tumors removable

NCT ID NCT07406126

First seen Feb 22, 2026 · Last updated May 07, 2026 · Updated 14 times

Summary

This study tests whether a targeted radiation treatment called Y90 radioembolization, given alongside standard chemotherapy, can shrink liver tumors that have spread from colorectal cancer. The goal is to make these tumors removable by surgery in people who were initially not candidates for surgery. The study will enroll 30 participants and monitor safety, tumor shrinkage, and immune markers.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL LIVER METASTASES (CRCLM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital Provincial de Castellón

    Castelló, Spain

    Contact Email: •••••@•••••

    Contact

  • Hospital Universitario Ramón y Cajal

    Madrid, Spain

    Contact Email: •••••@•••••

    Contact

    Contact

  • Hospital Universitario Virgen de las Nieves

    Granada, Spain

    Contact Email: •••••@•••••

    Contact

  • Hospital Universitario de Navarra

    Pamplona, Navarre, Spain

    Contact Email: •••••@•••••

    Contact

  • Hospital Universitario y Politécnico la Fe

    Valencia, Spain

    Contact

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.